Blood Collection From Individuals With Lung Disease for Genetic Studies
This is a research study where researchers are collecting blood to evaluate the genetic characteristics of individuals with chronic lung diseases, including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, cystic fibrosis, and lung cancer.
Ask AI to explain this studyKey things to know
This describes the study’s primary purpose.
The study team can explain what participation involves.
These are broad labels—not an eligibility decision.
Checked against the public recordLast updated Apr 29, 2016 · Source: ClinicalTrials.gov
Ask the study team to confirm whether enrollment is open.
Observational
Locations may change over time.
Study sponsor
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Weill Medical College of Cornell University
- Interventions being studied
- Not specified
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.
- Must provide informed consent
- Males and females, age 18 years and older
- Lung disease proven by at least one of the following:
- symptoms consistent with pulmonary disease
- chest X-rays consistent with lung disease
- pulmonary function tests consistent with lung disease
- lung biopsy consistent with lung disease
- family history of lung disease
- disease of organs with know associated with lung disease
- individuals suspected of history of lung disease based on history and/or physical examination
- normal controls (individuals without history of lung disease) to be sampled to provide a comparison to the lung disease cohort.
- Drug and/or alcohol abuse within the past six months
- Females who are pregnant or nursing
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- New York Presbyterian Hospital -- Weill Cornell Medical College of Cornell UniversityNew York, New York
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 29, 2016. Always confirm current availability with the study team.